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Abstract: Microbial biofilms are a major impediment to the use of indwelling medical 
devices, generating device-related infections with high morbidity and mortality. Major 
efforts directed towards preventing and eradicating the biofilm problem face difficulties 
because biofilms protect themselves very effectively by producing a polysaccharide 
coating, reducing biofilm sensitivity to antimicrobial agents. Techniques applied to 
combating biofilms have been primarily chemical. These have met with partial and limited 
success rates, leading to current trends of eradicating biofilms through physico-mechanical 
strategies. Here we review the different approaches that have been developed to control 
biofilm formation and removal, focusing on the utilization of acoustic energy to achieve 
these objectives.  
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1. Introduction 
 
Indwelling medical devices have become major tools in the clinical management of hospitalized 
patients, particularly those requiring life supporting devices. Urinary, intratracheal, central vein, 
peritoneal dialysis nephrostomes and other indwelling devices are becoming increasingly frequent in 
medical practice and are applied to more than 25% of hospitalized patients. However, as the duration 
of their placements become prolonged, risk factors related to microbial infections and biofilm 
formation culminate in higher morbidity and mortality rates among hospitalized patients, and sending 
the costs of hospitalization spiraling upwards. Most circulatory and urinary tract infection cases are 
associated with indwelling medical devices [1]. Microbial biofilms develop on the surfaces of medical 
devices and proceed to cause full blown bacterial infections and sepsis. In patients with urinary 
catheters, infection rates increase with the duration of catheterization at rates of 5-10% per day with 
virtually all of those who undergo long-term catheterization (>28 days) becoming infected [2-4]. 
Estimates by Costerton attribute more than half of bacterial infections in immuno-compromised 
patients to slime encased microbial colonies (biofilms) [5]. The U.S. National Institutes of Health 
mention infection rates as high as 80% that are due to microbial biofilms [6]. 
The magnitude of the biofilm problem and its impact on medical and financial aspects of modern 
hospital medicine have triggered the investment of major efforts to develop novel anti-biofilm 
strategies based on thorough, in depth analyses of the microbial transformation cascades. The rationale 
has been to develop means for disruption of colony formation at multiple sites of these transformation 
cascades and for eradication of existing biofilms. The composition of inert surfaces and intersurfaces 
has come under review as these form substrates to which unicellular planktonic microorganisms attach 
to enable their transformation into the multicellular sessile forms.  
The encasing slimy exopolysaccharide matrix which is secreted by the microorganisms and in 
which developing colonies become encapsulated, is another major target. This unique architecture 
regulates exchange of ions, chemicals and nutrients with the surrounding environment. It thus protects 
biofilms from external insults by blocking entry of biocides, surfactants and predators and renders 
them 1,000 times more resistant to antibiotics compared to free floating bacteria. [7,8]. In addition to 
acting as transport barriers to agents harmful to biofilms [9], exopolysaccharide matrix polymers also 
bind to and neutralize antibiotics prior to their interaction with bacteria [10]. Even if the antibiotics are 
successful in penetrating into the biofilm other researchers suggest that bacteria within biofilms are 
dormant and do not actively metabolize antibiotics [11].  
 
2. Biofilms and Anti-Microbial Immunity 
 
Microbial cells within biofilm colonies are also much less susceptible to host immune mechanisms. 
Key antigens are either repressed or concealed from effector immune cells [12], and bacteria in 
colonies are highly resistant to phagocytosis by immune system phagocytes [12]. Deposition of 
complement C3b and IgG on bacterial surfaces has also been shown to be prevented as demonstrated 
for  Staphylococcus epidermidis [13],  contributing to protection of bacteria from killing by 
polymorphonuclear leukocytes. Furthermore, in airways of cystic fibrosis patients the presence of 
polymorphonuclear leukocytes has even been found to enhance Pseudomonas auruginosa biofilm Sensors 2009, 9                              
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formation due to bacterial binding to F-actin and DNA polymers [14]. Thus, the various arms of anti-
microbial immunity are neutralized by the biofilm exopolysaccharide protective matrix, leaving 
affected patients fully vulnerable to the problem. 
Of interest are results of studies which have evaluated the effects of effector molecules of innate 
immune mechanisms on formation and survival of various types of microbial biofilms. Molecules such 
as lactoferrin, a constituent of human external secretions, have been found to inhibit development of 
Pseudomonas aeruginosa biofilms at lactoferrin concentrations lower than those that kill or prevent 
growth of the planktonic cells. The authors suggest that by chelating iron lactoferrin stimulates 
twitching surface motility, causing dispersion of bacteria rather than formation of the cell clusters 
required to form biofilms [15]. The importance of these observations is in the principle which suggests 
existence of a specific anti-biofilm formation protective mechanism. It acts at the stage in which 
bacteria begin to aggregate to form communities that subsequently transform into the sessile form of 
life [15]. Lactoferrin, however did not prevent fungal biofilm formation. This could be partially 
achieved by using oxidative and non-oxidative antimicrobial molecules produced by phagocytic cells 
such as PG-1, β-defensin-1, and β-defensin-3, which significantly reduce the metabolic activity in the 
biofilm [16]. Altogether immune reactions do not effectively inactivate biofilms but rather further 
invigorate the unique and highly resistant properties of microbial biofilms. The compromise of anti-
microbial immune mechanisms is the basis for the difficulties in eradicating this major source of 
microbial infection, explaining the severity, persistence and high morbidity associated with biofilm-
derived infections.  
 
3. Chemical Approaches, To Biofilm Elimination 
 
Chemical modifications constitute the main strategy being contemplated for biofilm elimination on 
indwelling medical devices. In one such approach catheters are coated with antimicrobial agents such 
as antibiotics, biocides such as chlorohexidine or with ion coatings with silver and to a lesser extent 
with zinc. These interfere with the attachment and expansion of immature biofilms. According to 
Riley, who conducted the largest randomized clinical trial with silver impregnated urinary catheters in 
1,309 patients, the silver coating was not found to be efficacious in preventing bacteriuria and on the 
contrary, increased incidence of staphylococcal bacteriuria has been reported to occur with silver 
coated catheters [17]. Unlike the findings with urinary catheters, evaluation of silver coatings on 
endotracheal tubes aimed at preventing ventilator-associated pneumonia (VAP) yields far more 
promising results. This study, conducted in a large single-blind, controlled study by the NASCENT 
Investigation group, enrolled 9,417 adult patients in 54 centers in North America. The incidence of 
VAP based on quantitative cultures from bronchoalveolar lavage fluids, has been evaluated. VAP was 
found to decline from 7.5% per > 24 hrs of intubation with uncoated endotracheal tubes to 4.8% in the 
group receiving the silver-coated tubes [18]. The study concluded that patients who received silver-
coated endotracheal tubes had statistically significant reductions in VAP incidence and experienced 
delays in the time to VAP occurrence compared with patients who received similar, uncoated tubes 
[18]. Another important conclusion from the urinary versus endotracheal catheter studies is that 
different results may be obtained for different types of catheters and each catheter type should be 
evaluated separately irrespective of results obtained with other catheter types. Sensors 2009, 9                              
 
 
2541
In patients requiring prolonged intravenous catheterization, microbial colonization of the 
intraluminal surfaces, generates biofilms that cause serious catheter-related bloodstream infections. To 
prevent these infections and salvage the central vein catheters an intraluminal antimicrobial lock 
therapy has been developed. The lock therapy involves sequestration of 2 to 4 mL of biocides in the 
catheter at concentrations 100-1,000-fold higher than the maximal dose that can be used systemically. 
The solution is allowed to dwell (lock) when the catheter is not in use, eradicating the bacteria and 
fungi embedded in the intraluminal biofilms [19]. Combinations of vancomycin and heparin have been 
frequently used in antimicrobial lock therapy however, these met with only partial success [20,21]. 
Use of minocycline and EDTA in lock times of 4 hrs, have proven to be more effective against 
bacterial biofilms [22]. Supplementation with the antifungals echinocandins- Caspofungin and 
micafungin, (1,3)-beta-D-glucan synthase inhibitors have been suggested to expand the effective range 
to also include fungal colonies [23].  
Another implant setting in which biofilms formed by Staphylococcus epidermidis cause pathologic 
reactions, is found in silicone breast implants. The problem of capsular contracture formation is 
traditionally addressed by systemic administration of antibiotics combined with antiseptic washings. 
Yet, a recently developed in vitro model for silicone breast implants suggests that combinations of 
chloramphenicol (Chloramex
®), sodium fusidate (Fucidin
®) and terramycin are likely to yield better 
results [24]. This model has yet to receive clinical confirmation. 
Interference with the attachment or adhesion of microorganisms to solid substrates, which is the 
first essential step of colonization, is a strategy that has been used for quite some time in the struggle 
against microbial biofilm formation. Bacterial adhesion is a broad and heterogeneous phenomenon as 
bacteria attach to a range of substrates, from indwelling catheters to epithelial tissues of the skin and 
GI, urinary and respiratory tracts. Adhesion is mediated by lectin-like, carbohydrate binding molecules 
known as adhesins. Several organelles have evolved to mediate the adhesion process including pili 
[25,26], fimbriae [27], flagellae [28] and outer membrane proteins [29]. They interact with 
carbohydrates present on cells and other surfaces in specific manners. Initial efforts have been to 
interfere with microbial attachment to surfaces via specific interventions that block carbohydrate 
binding sites. Mannosides and sialic acid compounds were used to target type I and type IV pili, 
respectively, however carbohydrate specific intervention strategies could not address the microbial 
adhesion problem at large. Multiple adhesion mechanisms have evolved on bacteria including non 
specific forms of adhesion, which do not appear to involve specific adhesins. For example when 
bacteria reach very close proximity to solid surfaces, at distances of 2 to 50 nm they are found within 
the range of van der Waals, hydrophobic, ionic, and electrostatic interaction forces [30]. Adhesion is 
initiated, mediating steps essential for promoting bacterial invasion and pathogenesis. In addition, 
surface binding mechanisms used by different microorganisms, are heterogeneous. Pseudomonas 
aeruginosa pili bind to asialoGM1 [31], whereas E. coli pili target mannosides and E. coli fimbriae N-
acetyl glucose amine [32]. This heterogeneity is also supplemented by additional mechanisms such as 
secretion of enzymes as neuraminidase, which remove surface sialylated sugars. Microbial binding 
targets are modulated exposing cryptic binding ligands [33,34]. These further complicate development 
of strategies for both prevention of biofilm formation and eradication of existing biofilms. 
A different and more successful prevention strategy of microbial adhesion and biofilm 
development, targets the surfaces of devices to reduce their compatibility with microbial cell Sensors 2009, 9                              
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attachment and improve their anti-microbial cytotoxicity. A broad range of chemical modifications of 
device surfaces have been developed to form unique contact-killing surfaces and biomaterials that are 
incompatible with adhesion. All-silicone, silicone-coated latex and nitrofurazone silicone catheters 
have been used in some cases in combination with hydrogel, hydrogel/silver-coatings of latex or 
silicone-based, silver-impregnated catheters. These strategies have been evaluated for prevention of 
nosocomial urinary tract infections and found to be ineffective in preventing biofilm formation. Use of 
silver alloy coated Foley catheters rather than silver ion coated ones did reduce the frequency of 
catheter acquired urinary tract infection with effects that exceeded one week of catheterization, 
however overall the effects were mainly short lived and declined after catheterization intervals of one 
week [35,36]. 
The most effective biofilm prevention method reported thus far has been achieved by coating of 
ureter polyurethane stents with heparin. The coating was shown to provide effective prevention of 
biofilm development compared with uncoated stents in vivo. Inhibitory effects persisted for 6 - 8 
weeks of indwelling [37]. 
The coating of indwelling catheters with various types of antibiotics or other disinfectants is 
associated with their leaching over time from the catheter surfaces to surrounding tissues. The leaching 
leads to reduced concentration of the anti-microbial agent on the catheter surface rendering any 
efficacy temporary and creating optimal conditions for development of resistant microbial strains. 
Recently, a novel concept in modification of device surfaces has been successfully developed. The 
new technology involves stable immobilization of anti-microbial agents on device surfaces via long 
and flexible polymeric chains covalently anchored to the device surface. Non-leaching contact-killing 
surfaces are produced. The developers used the quaternary ammonium derivative - N-alkylpyridinium 
bromide as the antimicrobial agent which was attached to a poly(4-vinyl-N-hexylpyridine) used as the 
anchoring carrier of the polymer [38]. The polymer was capable of inactivating ≥99% of S. 
epidermidis, E. coli, and P. aeruginosa bacteria on glass slides processed as non-leaching contact-
killing surfaces in vitro. In their quest to characterize the structural requirements from polymers to be 
active as bactericidal agents the authors modulated the hydrophobicity and the positive charge by 
using several other backbone compounds and antimicrobial moieties. These studies  revealed the 
importance of positively charged polycationic chains in enabling the molecule to stretch out and 
generate bactericidal activity. A study in which sterile surfaces were created on paper or glass by 
forming a poly[2-(dimethylamino)ethyl methacrylate] polymer, was used to examine the question of 
whether the sterile surface kills bacteria or only inhibits their growth. The immobilized polymers 
which were sufficiently long for traversing the approximately 30 nm cell envelope were found to be 
cytotoxic and killed bacteria as well as fungi via mechanisms that were not susceptible to development 
of resistance. Most importantly, silicone rubber to which 3-(trimethoxysilyl)propyldimethyloctadecyl 
ammonium chloride was covalently coupled showed antimicrobial properties against adhering 
bacteria, both in vitro and in vivo. Rats in which the surface modified silicone rubber was implanted 
subcutaneously for three or seven days had infection at rates of seven out of eight silicone rubber 
implanted animals decline to one out of eight when the silicone rubber implants were coated with 
positively charged polycationic chains [39]. 
In addition to existence of non specific adhesion mechanisms, the general lack of antimicrobial 
efficacy of different chemical modification strategies are also thought to result from conditioning films Sensors 2009, 9                              
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which develop on the catheter surfaces. Such films arise as a result of incrustations with proteins, 
electrolytes and other organic molecules on indwelling devices. The incrustations develop shortly after 
device insertion, modify the outer surface of the device and conceal its antimicrobial agents, enabling 
in this way the formation of biofilms [40]. It will also be of interest to find out if non-leaching contact-
killing surfaces can maintain long term microbicidal activity on indwelling catheters in light of the 
"conditioning film" problem. Lubrication of catheter surfaces, have attempted to limit such 
encrustations. Hydrogel as a single lubricant or in combination with silver coating, have been 
examined, however as mentioned above, these were also ineffective in preventing bacterial biofilm 
formation on urinary catheters [41]. 
Other factors that contribute to the overall failure of chemical approaches to prevent biofilm 
formation on indwelling medical devices include increased resistance of bacteria in biofilms to 
antimicrobial agents. Increased resistance to antimicrobials could be due to markedly down-regulated 
metabolism in bacteria within biofilms [5]. Indeed, adhesion of bacteria to solid surfaces has been 
shown to lead to diminution in the number of genes that are expressed compared to planktonic 
bacteria. Factors repressing a large number of genes such as the σ factor render biofilm bacteria 
phenotypically different from planktonic ones [42]. This adds to the interference with the transport of 
antibiotics and biocides into biofilms by the slimy exopolysaccharide encasing [43,44], rendering the 
sessile colony lifestyle highly resistant to eradication to this very day. 
 
4. Biological Approaches to Bacterial Biofilm Eradication 
 
A novel and interesting approach that has recently emerged is to treat biofilms with lytic 
bacteriophages. The attractive element in this concept is the finding that phages produce 
polysaccharide lyases that act as endo-glycanohydrolases. These enzymes are depolymerases capable 
of degrading biofilm exopolysaccharide matrix polymer components. Phages can then penetrate the 
inner layers of the biofilm, infect bacteria in the colony and cause their lysis [45]. This approach is 
being used to treat Pseudomonas aeruginosa biofilms in cystic fibrosis patients by spreading aerosol 
that contains the phages [46]. Phages can also be engineered to express the genes encoding these 
polysaccharide lyases used to elicit the biofilm exopolysaccharide dissolution to possibly, expand the 
number of bacterial species that can be targeted by a phage [47]. 
 
5. Interference with Inter-Bacterial Signaling for Biofilm Formation 
 
Following attachment to solid surfaces bacteria secrete several classes of small, diffusible quorum 
sensing molecules also known as autoinducers. These molecules form concentration gradients that 
convey inter-bacterial signaling capable of modulating bacterial gene expression to patterns that 
transform the planktonic lifestyle into a sessile form [48-50]. Their activity promotes biofilm 
development and differentiation. Oligopeptides and N-acylhomoserine lactones are involved in group-
specific communications within gram-positive and gram-negative bacteria respectively, and boronated-
diester molecules in communication among both gram-positive and gram-negative bacteria [51-54]. 
Disruption of autoinducer signaling pathways have been hypothesized to help prevent biofilm 
formation and differentiation. Two approaches have recently been proposed for interfering with these Sensors 2009, 9                              
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biofilm differentiation-promoting signaling mechanisms: one is biological and the other is mechanical. 
The biological approach identified naturally occurring products such as furocoumarins, found in 
grapefruit juice, that are capable of inhibiting cell-to-cell autoinducer signaling between bacteria, 
inhibiting biofilm formation [55]. The authors reported >95% inhibition of all types of autoinducers, 
gram negative or gram positive specific, as well as interspecific classes. The efficacy of these 
compounds, were analyzed in a Vibrio harveyi based autoinducer bioassay and in biofilm formation 
assays by Escherichia coli, Salmonella typhimurium and Pseudomonas aeruginosa. Although they 
appear to be effective in vitro, these products have yet to prove their effectiveness in vivo; their routes 
of administration must also be delineated more precisely, as grapefruit juice consumption is abundant 
and not known to prevent life threatening infections due to bacterial biofilms.  
Quorum sensing signaling in bacteria has also been tackled through mechanical approaches aimed 
at disruption of the concentration gradients of the small molecule mediators. Ultrasonic acoustic 
energy is being investigated as a mean for disrupting quorum sensing signaling through induction of 
chaos in the concentration gradients. The aim is to prevent bacterial cell migration and assembly at 
sites of colony formation, interfering in this way with biofilm differentiation [51,56] as well as with 
induction of several additional anti-biofilm effects that are discussed later in this review.  
 
6. Uses of Acoustic Energy in Biofilm Prevention 
 
The inability to eradicate microbial biofilms by chemical means raises the prospect that mechanical 
strategies may deliver better outcomes. A favored mechanical approach has been the use of acoustic 
energy for preventing de novo formation of biofilms as well as for disrupting the integrity of existing 
ones. Multiple objectives were expected to be achieved with the use of ultrasonic energy: 
(1) Abrogation of the two initial steps in biofilm formation: adhesion of planktonic microorganisms to 
surfaces and the ensuing firm attachment to substrates [57]. 
(2) Creation of stable cavitation in biofilms to enable more effective penetration and transport of 
antimicrobials and biocides through their exopolysaccharide encasings. 
(3) Bypassing the obstacle of conditioning-films, which interfere with microbicidal coatings from 
reaching biofilms.  
(4) Creation of microstreamings, which disrupt autoinducer gradients and abolish its signaling. 
Another byproduct of microstreamings is enhancement of the rate of cellular metabolism. 
Ultrasound is presumed to improve oxygen and nutrient transport to cells within biofilms and to 
planktonic cells [54,58], resulting in acceleration in the metabolic rates of the cells. The elevated 
metabolic rates may render bacterial cells more susceptible to antibiotics [58]. The hypothesis is 
that by invigorating the rate of bacterial cell metabolism ultrasound improves the efficiency of 
antibiotics.  
(5) Infliction of mechanical damage to existing biofilms. 
Indeed, in studies performed in E. coli and Pseudomonas aeruginosa, in vitro ultrasonication has 
been found to significantly increase transport of antibiotics (gentamicin) across biofilms, enhancing 
the killing of bacteria within the biofilm encasing [59]. However, in the absence of the antibiotic these 
same ultrasonic parameters (continuous ultrasonication at a frequency of 500 kHz and power density 
of 10 mW/cm
2, in vitro), did not alter neither the Pseudomonas aeruginosa biofilm structure, nor cell Sensors 2009, 9                              
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organization within these biofilms. Confocal scanning laser microscopic (CSLM) analyses revealed 
that these structures remained intact [60]. 
In vivo, the susceptibility of biofilms produced by different types of bacteria to ultrasound-enhanced 
transport of antibiotics is differential. Viability of E. coli biofilms formed on implants has been found 
to decrease significantly following simultaneous administration of gentamicin with pulsed low 
frequency ultrasound (1:3 duty cycles applied at power intensity of 500, mW/cm
2 for 24 and 48 hrs). 
Such reductions have not been observed in experiments conducted with Pseudomonas aeruginosa 
biofilms  [61-63].  The authors offer several explanations for the observed differences between 
treatment susceptibilities of the two types of biofilms in vivo. (1) Existence of differences in 
permeability of the outer membranes of the two bacteria  [60-62,64-66], (2) higher efficacy of 
aminoglicosides against metabolically active E. coli bacteria which may be more active in this model 
[67], and (3) oxygen limitations in the implant environment that may render E. coli biofilms more 
susceptible to antibiotics. 
These findings were confirmed by Ensing and co-workers [68]. They have shown that application 
of ultrasound at frequencies of 28-48 kHz and maximal intensity of 500 mW/cm
2 combined with 
gentamicin administered systemically or released from antibiotic-loaded bone cement, reduced 
bacterial viability in E. coli biofilms by >50% [68]. Combinations of pulsed ultrasound with an 
antibiotic released slowly from bone cements (preloaded with antibiotics) were found to significantly 
reduce the viability of both planktonic bacteria and biofilms from clinical isolates, compared to 
antibiotics released in the absence of acoustic energy [69]. Here too, the effect could not be produced 
successfully in P. aeruginosa.  
The selectivity in responsiveness to combinations of ultrasound and antibiotics, with some bacteria 
being affected whereas others are not renders importance to evaluation of the responsiveness of 
Staphylococcus epidermidis. Gram positive bacteria such as S. epidermidis are commonly found in 
infections affecting orthopedic and other types of implants [70]. These bacteria were subjected to 
combination treatments with low frequency ultrasound and systemic vancomycin for 48 hrs in a rabbit 
model. The viable bacterial counts were reduced significantly by the combined treatment with 
ultrasound and antibiotics relative to antibiotic treatment alone. Prolongation of the duration of the 
combination treatment also appeared to enhance the biocidal effects [71]. 
The partial and incomplete reductions in bacterial counts within biofilms, obtained with combined 
treatment with acoustic energy and antibiotics, prompted search for additional improvements in 
biofilm eradication efficacies. These were sought by further adding proteolytic enzymes to treatments 
applied to solid surfaces. Oulahal-Lagsir and co-workers applied treatments with 40 kHz of ultrasonic 
energy for durations in the range of 10 seconds combined with applications of protease for 15 minutes 
or trypsin for 30 min. These combinations yielded synergistic effects of higher efficacies, removing 
84-95% of E. coli biofilms compared to 30% with acoustic energy alone [72]. Although initially 
developed for the food industry, these combinations may form a basis for modifications that will 
involve endogenous human proteases for use on medical devices. 
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7. Complexity of High Frequency Acoustic Energy Effects on Biofilms and the Need for 
Improved Understanding of the Phenomenon  
 
The high potential embedded in the use of ultrasonic acoustic energy for preventing, suppressing 
and disrupting many aspects of biofilm life attracted extensive research efforts aimed at bringing it to 
clinical use. Since various laboratories used different systems, contradictory findings soon emerged. In 
contrast to the biocidal effects of combinations of antibiotics and ultrasound, Pitt and colleges found 
that low intensity ultrasound (2 W/cm
2) administered at a low frequency of 70 kHz as a sole treatment, 
enhances growth of both S. epidermidis, E. coli and P. aeruginosa biofilms as well as their planktonic 
forms.  This was presumed to result from improved oxygen and nutrient transport to cells within 
ultrasound treated biofilms and planktonic cells [58]. 
The conflicting results obtained when parameters of acoustic energy used in anti-biofilm 
microbiology were varied revealed the complexity of the system. It also highlighted the variability 
associated with the type of endpoints which were sought – biofilm prevention versus biofilm 
eradication. Each appears to require for optimal activity very different types of acoustic energy, 
varying in both frequency and intensity. Thus, the levels of ultrasonic energy that are applied may play 
crucial roles in the outcomes of treating existing biofilms or in preventing their de novo formation.  
For example, high ultrasonic power density levels were found to be highly effective in stripping 
surfaces from existing biofilms. Surfaces covered by 10
9 CFU/mL of bacteria could be cleaned by 
axially propagated ultrasound (APU) [71]. APU applied as 30 second pulses at intensities of 35-45 
Watts or 6-9 W, using probes suitable for frequencies of 350 kHz, 150 kHz and 20 kHz, respectively, 
effectively removed Proteus mirabilis biofilms from water-filled glass tubes. However, here too 
efficacy was inversely related to the frequency used. Treatment with 20 kHz proved the most efficient, 
removing 87.5% of the biofilm from 50 cm tubes, whereas APU applied at 150 kHz and 350 kHz 
removed only 66.8% and 31.3% of biofilms, respectively [72]. 
The complexity of factors involved in the use of acoustic energy in biofilm biology, become all the 
more evident when prevention of de novo formation of biofilms is sought. Unlike eradication, 
prevention of biofilm formation involves entirely different mechanisms such as interference with 
adhesion to solid surfaces, with formation of quorum sensing molecular gradients that affect biofilm 
differentiation and others. The acoustic energy properties required to effectively interfere with these 
mechanisms prove to be unique for each of the indications. 
In a set of elegant studies Pitt and colleagues analyzed and defined the requirements for effectively 
interfering with biofilm formation using acoustic energy. They postulated that when bacterial vibration 
amplitudes are smaller than those of surfaces located at close vicinity, a relative velocity of bacteria 
respective to the surface occurs as governed by Stoke’s law [58]. When the bacterial vibration 
amplitudes are smaller than the  (Zeta) potential, a repulsive zone develops in the vicinity of a solid 
surface and an overall net repulsion occurs that prevents bacterial attachment. Increasing the bacterial 
vibration amplitudes to values exceeding the  potential repulsion zone, results in a net attraction force 
that promotes the adhesion of bacteria [73,74] yielding opposite results. Systems that conform to such 
conditions have been found to effectively prevent the initial steps in biofilm formation - the adhesion 
and firm attachment of microorganisms to the catheter surfaces. These systems include the one which 
we have developed, which is discussed hereunder. Sensors 2009, 9                              
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8. Fine Tuning the Acoustic Energy Properties is Required for Each Type of Indwelling Catheter 
 
Elaborate fine tuning of the vibration energy properties is emerging as a requirement for obtaining 
effective prevention of biofilm formation on different types of indwelling medical devices. We noted 
this requirement when we devised an innovative approach to prevent biofilm formation on catheters. It 
involved development of small piezoelectric elements which we attached to solid surfaces and to 
extracorporeal sections of catheters. The piezo elements generate low energy acoustic waves and this 
energy is delivered directly to the catheter. The waves spread throughout the catheter and its surfaces, 
covering the catheter with a vibrating coat that is also dispersed throughout the surrounding fluid 
media, causing the bacteria to vibrate with the same frequency [75]. Conditioning films encrusted with 
proteins, electrolytes and other organic molecules which are known to develop on urinary catheters 
shortly after their insertion [36,40] do not appear to interfere with biofilm prevention by the low 
energy acoustic waves [75]. 
Our findings show that certain power intensities (Point < 1.1 mW/cm
2 and frequencies of 100-300 
kHz) appear to constitute the optimal acoustic energy levels for preventing biofilm formation on 
urinary catheters. This type of low acoustic energy inhibits bacterial attachment and biofilm formation 
on catheter surfaces significantly as evident from scanning electron microscopic (SEM) analyses as 
shown in Figure 1 and discussed in [75]. 
 
Figure 1. Effects of low levels of acoustic energy on bacterial attachment and biofilm 
formation on a urinary catheter. Scanning electron microscopic analysis of a French 8 
urinary catheter (a) connected to a Piezo electric element emitting 0.2 mW/cm
2 of vibration 
energy, and (b) catheter with a non vibrating element. The catheter was immersed in a 
suspension of E. coli bacteria for 48 hours. 
(a)  Active sample  (b)  Non vibrated control 
    
 
In studies we conducted in vitro on four types of microbes, E. coli, Enterococcus faecalis, Candida 
albicans and Proteus mirabilis SEM analyses revealed that the piezo element-generated acoustic 
waves reduced the viable microbial counts on the catheter surfaces significantly, and effectively 
diminished biofilm formation [75]. Catheters remained virtually clean of adherent microorganisms, 
indicating that this technology is efficacious against a broad spectrum of microorganisms and not 
limited to selected groups. The surface acoustic waves create chaotic microstreaming, which interferes 
with bacterial attachment as well as with post attachment biofilm developmental processes. 
Increasing the acoustic energy power intensity levels or the wave frequencies resulted in a dramatic 
shift from inhibition to strong enhancement of biofilm formation. These higher acoustic energy Sensors 2009, 9                              
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intensities activate bacterial docking and force sensor activities and this synergism can elicit the 
increased adhesion of bacteria [75]. 
A model which shows this shift from inhibition to strong enhancement in bacterial adhesion with 
increased acoustic energy output is the mannose receptor-mediated adhesion of E. coli to guinea pig 
erythrocytes. This specific adhesion occurs via E. coli FimH lectin binding to mannosides on surfaces 
of guinea pig erythrocytes. Adhesion of the bacteria to erythrocytes, causing their aggregation is 
effectively inhibited by low acoustic energy levels. In fact the optimal range of acoustic energy that 
inhibits E. coli adhesion to the red blood cells is even lower than the levels that inhibit adhesion to 
catheters (ranging between 0.05-0.20 mW/cm
2). In contrast, increasing the piezo element-generated 
acoustic energy to > 0.35 mW/cm
2 again induced opposite effects with strong bacteria-mediated RBC 
adhesion and enhanced aggregation [75]. 
The most important findings in these studies were obtained in a rabbit model in vivo. Indwelling 
urinary catheters inserted into the meatus of male rabbits and vibrated via the attached actuators 
enabled the maintenance of catheter sterility for 7.3 + 1.3 days (up to 9 days), whereas, control rabbits 
developed bacteriuria of >10
5 CFU/ml within 1.5 + 0.6 days [75]. 
The sharp transition to opposite effects on biofilm development that occur in the presence of 
different acoustic energy dose/frequency levels, reveal a major weakness in utilization of piezo-
element generated acoustic energy for preventing biofilm formation on indwelling catheters. The 
problem stems from difficulties in precisely controlling the acoustic energy output from the piezo 
actuators. Somewhat higher outputs enhance bacterial attachment to the catheters and promote biofilm 
differentiation rather than inhibit them. Thus, the application of surface acoustic waves to various 
types of medical devices requires meticulous adjustments of frequencies and amplitudes for each type 
of targeted catheter. 
 
9. High Energy Ultrasound 
 
Ultrasonic energy used in the combat against microbial biofilms is divided into two categories with 
respect to the effects it produces: power intensities that cause cavitation are energy levels in excess of 
the cavitation producing energy thresholds. These are wave frequencies f > 100 kHz generated at 
acoustic power intensities of 0.5-2x10
3 mW/cm
2. A second category includes the lower power 
intensities that do not form cavitations [76]. The high acoustic energy power intensity levels are more 
suitable for eradication of existing biofilms rather than preventing their formation. 
Biofilm removal was found to strongly depend on the intensity of acoustic energy and to a far lesser 
extent on the frequency [77]. The author reported that coupling the acoustic energy with convective 
fluid flow dramatically improved biofilm removal at acoustic intensity of 27 W/cm
2 (removal of up to 
80% of biomass in two minutes and close to 100% when intense ultrasonication was coupled with gas 
bubbles in the fluid) [77, 78]. Unlike these power intensity doses prevention of biofilm formation is 
effective upon transmission of much lower acoustic energy intensity levels (< 0.35 mW/cm
2) [75]. 
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10. Future Outlook and Conclusions 
 
Despite significant breakthroughs in biofilm prevention and eradication technologies, current relief 
is only short lived, limited to certain types of catheters and unsuitable for others. In many cases 
efficacy is seen on some types of bacteria and not on others. The likelihood for broadening the 
spectrum of chemical anti-biofilm specific reagents may depend on the identification of the entire 
spectrum of saccharides, proteins, mucins and lipids that the various bacteria can target for microbial 
adhesion. One would then be required to develop combinations of inhibitors that can counteract each 
of the receptors.  
The current outlook for the general and non-specific anti-biofilm arena is more likely to employ 
mechanical means in the form of various types of acoustic energy. Arrays of modifications and 
adjustments that will render the low acoustic energy conditions suitable to different indwelling medical 
devices, are likely to expand its scope of use and may render this technology suitable for utilization in 
central vein catheters and possibly also in endotracheal as well as other catheters. There is also the 
potential of utilizing acoustic energy to prevent biofilm formation on organs and not only on devices. 
One example which we have begun to evaluate is prevention of intra-tracheal biofilm formation, a 
utilization that may be of importance for patients with cystic fibrosis. Preliminary studies on sheep 
trachea reveal the complexity of applying this concept even before addressing the problem of the high 
intolerance of the airways to foreign bodies.  
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